Nvar epsilon(γ-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia

Nvar epsilon(γ-glutamyl)lysine isodipeptide is released from the breakdown of proteins cross-linked by transglutaminase enzymes. Transglutaminase activation is a marker of apoptosis and elevated isodipeptide concentrations in body fluids might correlate with the intensity of apoptotic cell turnover. The concentration of Nvar epsilon(γ-glutamyl)lysine was measured in the cerebrospinal fluid (CSF) of patients with probable Alzheimer’s disease (n = 14) and vascular type dementia (n = 11) and compared with not demented surgical controls (n = 17). Baseline levels of 26–62 nM/l (mean 37.9 ± 8.7 SD) free isodipeptide were detected in control patients. CSF isodipeptide levels showed significant elevation in vascular (mean 95.6 ± 45.1 SD) as well as Alzheimer patients (176.6 ± 77.1 SD). Isodipeptide concentrations above 120 nM/l were 72% specific and 77% sensitive to Alzheimer’s dementia, although the difference between the two dementias was statistically insignificant (p > 0.05). Determination of CSF Nvar epsilon(γ-glutamyl)lysine isodipeptide concentration offers a novel method for measurement of neurodegeneration in primary and mixed dementias.